Physician

Jessica Lauren Stulc, MD

According to 2025 Medicare claims, Jessica Stulc, MD (NPI: 1225271646) practices neurology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Hennepin, MN. This provider's primary affiliated billing organization is MINNEAPOLIS CLINIC OF NEUROLOGY, LTD (NPI: 1992739247; TIN: 410999094) and primary practice location at 55422-4215. Stulc is affiliated with the Central Minnesota ACO, LLC (ACO ID: A2844), Caravan Collaborative Pathways (ACO ID: A4604), Avera Prairie View ACO (ACO ID: A4692), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Stulc's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 229 traditional Medicare patients, billed 62,742 HCPCS/CPT codes, and received $2,577,458 in Medicare payments. The top billing code was 72156 (Mri scan of upper spinal canal before and after contrast). Part D data shows 3,612 prescription claims across 348 beneficiaries totaling $3,283,590 in drug costs, led by Kesimpta Pen (Ofatumumab). 2022 DME data shows 24 claims. Open Payments data shows 145 records totaling $464,031. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $29,256 to $2,577,458. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $975 to $76,724.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	86	239	$29,256
2016	104	302	$36,582
2017	147	514	$65,188
2018	163	433	$60,091
2019	222	625	$86,759
2020	267	25,517	$961,303
2021	250	49,065	$1,834,750
2022	223	58,128	$2,315,466
2023	227	61,337	$2,744,113
2024	229	62,742	$2,577,458

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	120	646	$359,023
2016	138	1,108	$1,098,525
2017	241	2,509	$3,760,965
2018	268	3,274	$5,002,623
2019	276	3,420	$4,525,346
2020	288	3,476	$5,091,414
2021	298	3,496	$4,778,683
2022	300	2,962	$5,012,300
2023	320	3,159	$4,219,335
2024	348	3,612	$3,283,590

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	37	$852
2018	N/R	27	$1,343
2019	N/R	11	$364
2020	N/R	N/R	N/R
2021	N/R	27	$1,046
2022	N/R	24	$3,559
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
72156	Mri scan of upper spinal canal before and after contrast	48	52	$175
70553	Mri scan of brain before and after contrast	49	54	$175
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	99	136	$135
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	92	111	$93
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	147	195	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Kesimpta Pen	Ofatumumab	112	3,282	$1,031,685
Copaxone	Glatiramer Acetate	64	2,078	$439,207
Aubagio	Teriflunomide	29	870	$271,029
Betaseron	Interferon Beta-1b	17	700	$237,982
Rebif	Interferon Beta-1a/Albumin	23	644	$237,246

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$22,308	EMD Serono, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	116	$441,724	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jessica Lauren Stulc, MD?

Tedicare shows public-source Medicare data for Jessica Lauren Stulc, MD (NPI 1225271646), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jessica Lauren Stulc, MD have ACO affiliation data?

Jessica Lauren Stulc, MD is shown with ACO affiliation data for Central Minnesota ACO, LLC (MSSP, ACO ID A2844), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Avera Prairie View ACO (MSSP, ACO ID A4692), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Jessica Lauren Stulc, MD?

Jessica Lauren Stulc, MD is linked to MINNEAPOLIS CLINIC OF NEUROLOGY, LTD (billing NPI 1992739247) in the available physician profile data.

Does Jessica Lauren Stulc, MD have Open Payments data?

Jessica Lauren Stulc, MD has 145 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.